Prot #AT148005: A Phase 1/2 study of ALX148 in Combination with Venetoclax and Azacitidine in Patients with Acute Myeloid Leukemia (AML) (ASPEN-05)

Project: Research project

Project Details

StatusActive
Effective start/end date9/15/21 → 9/15/24

Funding

  • Pharmaceutical Research Associates, Inc. (Prot #AT148005)
  • ALX Oncology, Inc (Prot #AT148005)